Effects of anticancer drugs on transcription factor–DNA interactions

Author： Gniazdowski Marek Denny William A Nelson Stephanie M Czyz Malgorzata

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.3, 2005-06, pp. : 471-489

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methods for Elucidation of DNA-Anticancer Drug Interactions and their Applications in the Development of New Drugs

Current Pharmaceutical Design, Vol. 22, Iss. 44, 2017-01 ,pp. : 6596-6611

Bentham Science Publishers

Access to resources Recommend Favorite

Herbal Interactions with Anticancer Drugs: Mechanistic and Clinical Considerations

Current Medicinal Chemistry, Vol. 17, Iss. 16, 2010-06 ,pp. : 1635-1678

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging DNA topoisomerase inhibitors as anticancer drugs

By Denny William A

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 105-133

Informa Healthcare

Access to resources Recommend Favorite

Development of distamycin-related DNA binding anticancer drugs

By Marchini Sergio Broggini Massimo Sessa Cristiana D’Incalci Maurizio

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1703-1714

Informa Healthcare

Access to resources Recommend Favorite

Transcription Factors As Targets for DNA-Interacting Drugs

Current Medicinal Chemistry, Vol. 10, Iss. 11, 2003-06 ,pp. : 909-924

Bentham Science Publishers

Access to resources Recommend Favorite